Viridian Therapeutics Inc (VRDN) – Company Profile and SWOT Analysis
- Pages: 49
- Published: March 2026
- Report Code: MLME279932FSA
Viridian Therapeutics Inc (VRDN) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Viridian Therapeutics Inc (Viridian), formerly miRagen Therapeutics, focuses on the discovery and development of medicines for serious and rare diseases. The company’s major products in development are VRDN-001 and VRDN-003, which are aimed at treating thyroid eye disease (TED), and a portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, for autoimmune diseases. The company’s lead product candidate, VRDN-001, is an intravenous humanized monoclonal antibody targeting IGF-1R, and VRDN-003 is for subcutaneous administration, both aimed at treating thyroid eye disease (TED). The company develops novel RNA-based therapeutics, with a core focus on therapeutic antibodies and their roles in diseases. Viridian is headquartered in Waltham, Massachusetts, the US.
Scope
• Detailed information on Viridian Therapeutics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Viridian Therapeutics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Viridian Therapeutics Inc including a breakdown and examination of key business segments
• News about Viridian Therapeutics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Viridian Therapeutics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Viridian Therapeutics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Viridian Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Star Therapeutics Inc
Kiniksa Pharmaceuticals International Plc
Horizon Therapeutics Ltd
Sling Therapeutics Inc
Immunovant Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.